Cargando…
Removing global barriers to cervical cancer prevention and moving towards elimination
Cervical cancer is a disease of inequality. The majority of cervical cancer cases can be prevented through vaccination against the human papillomavirus (HPV) (primary prevention) and screening and early treatment of precancerous lesions caused by HPV infections (secondary prevention), and it can be...
Autores principales: | Alfaro, Karla, Maza, Mauricio, Cremer, Miriam, Masch, Rachel, Soler, Montserrat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353608/ https://www.ncbi.nlm.nih.gov/pubmed/34376828 http://dx.doi.org/10.1038/s41568-021-00396-4 |
Ejemplares similares
-
Affordable cancer technologies: Lessons learned from the design and implementation of two randomized clinical trials to develop innovative treatments for cervical precancer
por: Soler, Montserrat, et al.
Publicado: (2023) -
Cervical Cancer Prevention in El Salvador: Gains to Date and Challenges for the Future
por: Alfaro, Karla, et al.
Publicado: (2022) -
Outcomes for Step-Wise Implementation of a Human Papillomavirus Testing–Based Cervical Screen-and-Treat Program in El Salvador
por: Alfaro, Karla, et al.
Publicado: (2020) -
The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador
por: Campos, Nicole G., et al.
Publicado: (2019) -
Cervical cancer prevention in El Salvador (CAPE)—An HPV testing-based demonstration project: Changing the secondary prevention paradigm in a lower middle-income country
por: Maza, Mauricio, et al.
Publicado: (2017)